Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Tax Provisions (2016 - 2025)

Voyager Therapeutics (VYGR) has disclosed Tax Provisions for 6 consecutive years, with $9000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 98.46% to $9000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $144000.0 through Dec 2025, down 78.35% year-over-year, with the annual reading at $144000.0 for FY2025, 78.35% down from the prior year.
  • Tax Provisions hit $9000.0 in Q4 2025 for Voyager Therapeutics, down from $83000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $822000.0 in Q4 2023 to a low of -$177000.0 in Q3 2023.
  • Historically, Tax Provisions has averaged $184750.0 across 3 years, with a median of $40000.0 in 2024.
  • Biggest YoY gain for Tax Provisions was 164.29% in 2025; the steepest drop was 98.46% in 2025.
  • Year by year, Tax Provisions stood at $822000.0 in 2023, then dropped by 28.95% to $584000.0 in 2024, then tumbled by 98.46% to $9000.0 in 2025.
  • Business Quant data shows Tax Provisions for VYGR at $9000.0 in Q4 2025, $83000.0 in Q3 2025, and $15000.0 in Q2 2025.